Aminalon (Aminalon)

Archive
"Trade product
in Russia is not registered "
Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceGamma-aminobutyric acidGamma-aminobutyric acid
Similar drugsTo uncover
  • Aminalon
    pills inwards 
    AKRIKHIN HFK, JSC     Russia
  • Aminalon
    pills inwards 
    ORGANICS, JSC     Russia
  • Aminalon
    pills inwards 
    BORISOVSKIY FACTORY OF MEDPREPARATES, OJSC     Republic of Belarus
    • Dosage form: & nbspfilm-coated tablets
    Composition:

    One tablet contains:

    active substance: gamma-aminobutyric acid in terms of 100% of the substance - 250 mg;

    Excipients: sucrose - 25.6 mg, magnesium stearate - 4.4 mg.

    Shell composition: ready mix "Opadray AMB" of white color (polyvinyl alcohol - 45.52%, soy lecithin - 2%, xanthan gum - 0.48 %, talc - 20%, titanium dioxide - 32%) - 14 mg.

    Description:The tablets covered with a film cover, from white to white with a creamy shade of color, round, biconcave.
    Pharmacotherapeutic group:Nootropic remedy
    ATX: & nbsp

    N.03.A.G.03   Gamma-aminobutyric acid

    Pharmacodynamics:

    Nootropic agent, improves the metabolism of brain tissue, promotes the utilization of glucose by the brain and the removal of toxic metabolic products from it.

    It increases the productivity of thinking, improves memory, has a moderate psychostimulating effect, favorably affects the restoration of movements and speech after a disturbance of cerebral circulation.It has a mild hypotensive effect, reduces the initially high blood pressure and the severity of symptoms caused by hypertension (dizziness, insomnia), slightly, reduces the frequency of cardiac dyeing. Has moderate antihypoxic and anticonvulsant action. In patients with diabetes mellitus reduces the level of glycemia, with a normal glucose content in the blood there is an opposite effect (due to glycogenolysis).

    Pharmacokinetics:

    Absorption is fast, fairly complete. The time to reach the maximum concentration in the blood plasma is 60 minutes, then the concentration decreases rapidly, after 24 hours it is not determined.

    Indications:

    In adults:

    Residual phenomena of craniocerebral trauma, stroke; encephalopathy and polyneuropathy of various genesis (including alcoholic), a symptomatic complex of motion sickness ("sea" and "air" disease).

    In children from 3 years:

    cerebral palsy, consequences of birth trauma (from 3 years), intellectual deficiency with a decreased mental, activity, symptomatic complex of motion sickness ("sea" and "air" disease).
    Contraindications:

    Hypersensitivity to the components of the drug. Children under 3 years.Acute kidney failure. Pregnancy (I trimester) and lactation. Deficiency of sugar / isomaltase, intolerance to fructose, glucose-galactose malabsorption.

    Pregnancy and lactation:The drug is contraindicated in the first trimester of pregnancy and lactation. In the II and III trimester of pregnancy, the drug can be used only under the supervision of the treating doctor.
    Dosing and Administration:

    Inside, before eating. The daily intake for adults is 3-3.75 g; for children 3 years - 1-2 g / day, 4-6 years - 2- 3 g / day, over 7 years - 3 g / day. The daily dose is divided into 3 divided doses. Treatment is carried out for a long time (from 2-3 weeks to 2-4 months).

    For the prevention and treatment of adult motion sickness syndrome - 0.5 g and children - 0.25 g immediately before using vehicles, or 3 times a day for 3- 4 days.

    Side effects:Nausea; vomiting, insomnia, lability of blood pressure, hyperthermia (pass with decreasing dose). Perhaps the development of allergic reactions.
    Overdose:

    Symptoms: There may be an increase in the severity of side effects.

    Treatment: gastric lavage, reception of activated charcoal, symptomatic therapy.

    Interaction:

    Strengthens the action of benzodiazepines, hypnotics and antiepileptic drugs.

    Special instructions:There may be fluctuations in blood pressure.
    Effect on the ability to drive transp. cf. and fur:During the period of treatment, care must be taken when driving vehicles and engaging in other potentially hazardous activities requiring increased attention and speed of psychomotor reactions.
    Form release / dosage:

    Tablets, film-coated, 250 mg.

    Packaging:

    For 10 tablets in a planar cell package.

    5 or 10 contour mesh packages together with instructions for use in a pack of cardboard.

    Storage conditions:
    In a dry, protected from light place at a temperature of no higher than 25 ° C. Keep out of the reach of children.
    Shelf life:

    2 years. Do not use after the expiration date.

    Terms of leave from pharmacies:On prescription
    Registration number:LS-002213
    Date of registration:02.12.2011
    Expiration Date:Unlimited
    Date of cancellation:2016-10-03
    The owner of the registration certificate:AKRIKHIN HFK, JSC AKRIKHIN HFK, JSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp07.08.2017
    Illustrated instructions
      Instructions
      Up